fluconazole has been researched along with Cholera Infantum in 10 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with fluconazole, 200 mg/day, was introduced." | 5.29 | [Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS]. ( Boyvat, A; Geilen, CC; Orfanos, CE; Seibold, M; Tebbe, B; Wölfer, LU, 1996) |
| " Although fluconazole use has been considered one of the main causes for the epidemiologic change in invasive candidiasis, especially in the increase of species less sensitive to this agent, this association remains unproven." | 4.84 | [Current treatment of candidemia. Role of anidulafungin]. ( Almirante, B; Pemán, J, 2008) |
| " Therapeutic usage of amphotericin B, the agent of choice for serious Candida infection, is reviewed, along with usage of 5-flucytosine and fluconazole." | 4.78 | Pathogenesis and management of Candida infection syndromes in non-neutropenic patients. ( Solomkin, JS, 1993) |
| "Here, we present a case of Crohn's disease with gastrointestinal cryptococcosis that resembled exacerbation of Crohn's disease." | 1.48 | Disseminated cryptococcosis in Crohn's disease: a case report. ( Angkasekwinai, N; Chavapradit, N, 2018) |
| "Treatment with fluconazole, 200 mg/day, was introduced." | 1.29 | [Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS]. ( Boyvat, A; Geilen, CC; Orfanos, CE; Seibold, M; Tebbe, B; Wölfer, LU, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chavapradit, N | 1 |
| Angkasekwinai, N | 1 |
| Satrom, K | 1 |
| Gourley, G | 1 |
| Almirante, B | 1 |
| Pemán, J | 1 |
| Sidrim, JJ | 1 |
| Maia, DC | 1 |
| Brilhante, RS | 1 |
| Soares, GD | 1 |
| Cordeiro, RA | 1 |
| Monteiro, AJ | 1 |
| Rocha, MF | 1 |
| Solomkin, JS | 1 |
| Becherer, PR | 1 |
| Sokol-Anderson, M | 1 |
| Joist, JH | 1 |
| Milligan, T | 1 |
| Ponnuvel, KM | 1 |
| Rama, CP | 1 |
| Menon, T | 1 |
| Tebbe, B | 1 |
| Boyvat, A | 1 |
| Geilen, CC | 1 |
| Wölfer, LU | 1 |
| Seibold, M | 1 |
| Orfanos, CE | 1 |
| Gupta, AK | 1 |
| Gregurek-Novak, T | 1 |
| Nathwani, D | 1 |
| Green, ST | 1 |
| McGuire, W | 1 |
| Goldberg, DJ | 1 |
| Kennedy, DH | 1 |
3 reviews available for fluconazole and Cholera Infantum
| Article | Year |
|---|---|
Cholestasis in Preterm Infants.
Topics: Anti-Bacterial Agents; Antifungal Agents; Cephalosporins; Cholestasis; Enteral Nutrition; Enterocoli | 2016 |
[Current treatment of candidemia. Role of anidulafungin].
Topics: Adult; Aged; Anidulafungin; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Disease Suscep | 2008 |
Pathogenesis and management of Candida infection syndromes in non-neutropenic patients.
Topics: Amphotericin B; Candidiasis; Clinical Trials as Topic; Cross Infection; Fluconazole; Flucytosine; Fu | 1993 |
1 trial available for fluconazole and Cholera Infantum
| Article | Year |
|---|---|
Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
Topics: Adult; Antifungal Agents; Female; Fluconazole; Follow-Up Studies; Foot Dermatoses; Gastrointestinal | 2001 |
6 other studies available for fluconazole and Cholera Infantum
| Article | Year |
|---|---|
Disseminated cryptococcosis in Crohn's disease: a case report.
Topics: Amphotericin B; Antifungal Agents; Crohn Disease; Cryptococcosis; Disease Progression; Female; Fluco | 2018 |
Candida species isolated from the gastrointestinal tract of cockatiels (Nymphicus hollandicus): In vitro antifungal susceptibility profile and phospholipase activity.
Topics: Amphotericin B; Animals; Antifungal Agents; Bird Diseases; Brazil; Candida; Candidiasis; Cockatoos; | 2010 |
Gastrointestinal histoplasmosis presenting as hematochezia in human immunodeficiency virus-infected hemophilic patients.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Diagnosis, Differential; Fluconazole; Gastrointe | 1994 |
Systemic and gastrointestinal candidiasis of infant mice as model for antifungal therapy.
Topics: Amphotericin B; Animals; Candidiasis; Disease Models, Animal; Fluconazole; Flucytosine; Fungemia; Ga | 1993 |
[Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; C | 1996 |
New triazole antifungal agents (fluconazole and itraconazole) in the treatment of HIV-related gastrointestinal candidiasis.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candidiasis; Fluconazole; Gastrointestinal Di | 1989 |